The Report “Patient Registry Software Market by Delivery Mode (Subscription, Ownership), Functionality (Population Health Management, Point of Care, Care Management), Database (Diabetes, Cancer, Cardiovascular, Chronic & Rare Disease) & by End User - Forecast to 2019” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the patient registry software market along with the estimates and forecasts of the revenue.
The global patient registry software market is expected to reach $610.8 million by 2019 from $381.0 million in 2014, growing at a CAGR of 9.9% from 2014 to 2019.
The report segments this market on the basis of delivery model, product type, database type, functionality, and end user. Among various end users, the government organizations and TPAs segment is expected to account for the largest share in 2014. Government organizations and TPAs extensively use this software for population health management (PHM) and improving quality of care, which is a major reason for the high share of this end-user segment. The hospitals and medical practices end-user segment is expected to grow at the highest CAGR from 2014 to 2019, due to the increasing use of patient registry software for, and improvement of, quality care.
Based on region, the global patient registry software market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market by the end of 2014. The growth of this market is driven by factors such as increasing government initiatives for building patient registries, rising focus on patient care improvements, and increasing adoption of EHRs.
Get Customized Report: http://www.marketsandmarkets.com/requestCustomization.asp?id=144694594
Key players in the patient registry software market include Global Vision Technologies, Inc. (U.S.), ImageTrend, Inc. (U.S.), ifa systems AG (Germany), INC Research Holdings, Inc. (U.S.), McKesson Corporation (U.S.), Phytel, Inc. (U.S.), Quintiles Transnational Holdings, Inc. (U.S.), Optum, Inc. (U.S.), Telligen, Inc. (U.S.), and Velos, Inc. (U.S.), amongst others.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog http://mnmblog.org/market-research/healthcare/healthcareit
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets